CONNECT WITH US
HealthTech

HealthTech

HLTH 2026: Noom, Hims & Hers expand into booming peptide market

Fierce Healthcare logo

Published on

Add as a preferred source on Google
HLTH 2026: Noom, Hims & Hers expand into booming peptide market

LAS VEGAS—Direct-to-consumer health companies Noom and Hims & Hers are making a play for the booming peptide market as the federal government loosens restrictions on compounded treatments.

The companies are betting that peptides could be the next big thing in consumer health. For Noom, the new peptide offering extends the company's business beyond weight loss into the broader longevity and wellness market. Hims & Hers signaled months ago that it was ready to tap into the multi-billion-dollar peptide market.

Federal policy shifts and U.S. Food and Drug Administration enforcement discretion around compounded peptides have opened new pathways for telehealth and compounding pharmacies.

On Tuesday, Noom launched OpenRx as a separate peptide and preventive health brand. At launch, OpenRx offers two injectable options: sermorelin, a peptide frequently prescribed for muscle support, and NAD+, a coenzyme frequently prescribed for energy. OpenRx also offers two oral dissolvable tablet options: the first formulation combines the peptides PT-141 and oxytocin with tadalafil to support sexual health. The second ODT formulation is the peptide oxytocin to support intimacy.

Noom says it plans to expand into other areas including recovery, muscle health, skin, gut health and sleep. Peptides are small pieces of protein that occur naturally in the body and help control functions such as growth, healing and appetite.

“Peptides are an important portion of the formulary of healthy aging,” Geoff Cook, CEO of Noom, said in a statement. “OpenRx enables our flagship Noom brand to deepen into cardiometabolic health while the new brand OpenRx supports patients with conditions too often neglected by traditional care models, like energy, muscle composition, skin health, sexual health, sleep, and recovery.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.